Search - tctmd.com

Displaying 121 - 140 of 204

Sort: Relevancy | Date

News Conference News ACC 2020

Increased Physical Activity on Apple Watch Lowers BP

Yael L. Maxwell

March 23, 2020

News Opinion CV Team Dispatch

March 2020 News Roundup

L.A. McKeown

March 12, 2020

News Daily News

Better Adherence to Guideline Advice Pays Off After Acute MI

Yael L. Maxwell

March 11, 2020

News Conference News STS 2020

PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge

Yael L. Maxwell

February 03, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Daily News

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Yael L. Maxwell

October 22, 2019

News Conference News HFSA 2019

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

L.A. McKeown

September 24, 2019

News Conference News HFSA 2019

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

L.A. McKeown

September 23, 2019

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

ORION-11: Inclisiran Shows Promise, Safety in Largest Published Cohort

News Conference News ESC 2019

ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date

Yael L. Maxwell

September 03, 2019

News Conference News ESC 2019

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

Michael O'Riordan

September 02, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Ideal CV Health at Age 50 Foretells Lower Risk of Later Dementia

Marcus A. Banks

August 12, 2019

News Daily News

Adherence to US Physical Activity Guidance Flattens as Sedentary Time Creeps Up

Shelley Wood

July 26, 2019

News Daily News

Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events

Marcus A. Banks

July 25, 2019

News Conference News SCCT 2019

Retrospective Study Validates CAC-DRS Score for Predicting Mortality

Yael L. Maxwell

July 23, 2019

News Conference News SCCT 2019

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Yael L. Maxwell

July 19, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Conference News SCCT 2019

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

Yael L. Maxwell

July 16, 2019

News Conference News SCCT 2019

Time to Ease Up on Prior Authorization for PCSK9 Inhibitors?

Yael L. Maxwell

July 15, 2019

Advertisement

Increased Physical Activity on Apple Watch Lowers BP

March 2020 News Roundup

Better Adherence to Guideline Advice Pays Off After Acute MI

PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Ideal CV Health at Age 50 Foretells Lower Risk of Later Dementia

Adherence to US Physical Activity Guidance Flattens as Sedentary Time Creeps Up

Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events

Retrospective Study Validates CAC-DRS Score for Predicting Mortality

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

Time to Ease Up on Prior Authorization for PCSK9 Inhibitors?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content